Dear Louise,
With the costs of taking a drug successfully to market now spiralling to $2.6 billion, the critical need to reduce cycle time and improve accuracy in target identification and validation is clear.
In-depth consultation with your peers across global pharma & biotech has shown that the latest in machine learning, data mining, predictive informatics & advanced analytics are key to powering drug discovery and repurposing.
This research has culminated in the launch of Discovery Informatics & Analytics Summit 2016, the only industry event focused on the practical application of models and informatics specifically for drug discovery and repurposing.
So, do you want to find out how AstraZeneca, Berg, Janssen or GSK are accelerating drug discovery?
The event programme showcases unparalleled access to case studies and discussion groups led by these organisations to find out how to harness the latest in informatics analytics to:
- Unlock scientific insights from pre-clinical data sets
- Power drug discovery and repurposing from archived data
- Harness OMICs to cut through validation barriers
- Understand compound performance and viability through simulation
- Use text mining and image analysis techniques to delve deeper into current research
- Standardise complex data sets and promote translational medicine to deliver new insights
Join your peers at this launch event to ensure you have insight into the latest
industry leading models and applications to assist you in accelerating
discovery cycle time for your organisation.
To secure your place today, be sure to register online now at www.discovery-informatics.com, call +44 (0) 800 098 8489 or email info@lbcg.com
I look forward to seeing you there.
Kind regards,
Alexis May
Event Director
Discovery Informatics & Analytics Summit 2016
P.S. Register today and benefit from the early bird discount of £100
